-
Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting
Volkers, A., Löwenberg, M., Braad, M., Abeling, Y., Gecse, K., Berkers, N., Montazeri, N. & D’Haens, G., 1 May 2023, In: Diagnostics. 13, 10, 1712.Research output: Contribution to journal › Article › Academic › peer-review
- All publications